Apr 26, 2021 | COVID-19, Featured, Federal Issues
On this episode of the podcast, Terry and Bob discuss the Food and Drug Administration and its lessons learned from the pandemic. They highlight how best practices from Operation Warp Speed and research on Covid-19 long haulers can inform ongoing treatments for those...
Read more
Feb 6, 2021 | COVID-19, Featured
Season 2 | Episode 5 – Vaccines & Health Equity On this episode of the podcast, Terry and Bob discuss health equity in conjunction with Black History Month. The pandemic has exposed racial disparities in healthcare, including the relative lack of...
Read more
Jan 25, 2021 | COVID-19, Featured
By Surabhi Dangi-Garimella, Ph.D. Despite the initial stumbles, it looks like the wheels of the vaccination mobile have stabilized a bit in the U.S. Plans remain fluid on prioritizing who receives the vaccines developed to tackle the 2019 coronavirus disease...
Read more
Jan 25, 2021 | COVID-19, Featured
On this episode of the podcast, Terry and Bob discuss the slow Covid-19 vaccine rollout and point out which states are doing the best at distributing their vaccines. The most effective states, they note, are the ones that began their distribution plans back in the...
Read more
Oct 25, 2020 | COVID-19, Featured
On this episode of the podcast, Terry and Bob discuss the triumph of the forthcoming Covid-19 vaccines, which are on the cusp of development just nine months after the Covid-19 disease was sequenced. Unfortunately, they point out, the media is engaging in...
Read more
Oct 17, 2020 | COVID-19, Featured, Podcast
On this week’s episode of the podcast, Bob reprises his interview with Janet Woodcock, the director of the Center for Drug Evaluation and Research (CDER) at the FDA, about the hurdles to reshoring drug manufacturing to the U.S. Currently, roughly 80 percent of...
Read more
